Earnings
ZIOP
3.630
+0.83%
0.030
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
0.00
0.00
--
--
19.53M
38.33M
--
--
--
57.86M
--
-57.86M
0.00
--
-59.94M
0.00
-117.80M
--
-117.80M
--
-117.80M
-117.80M
--
--
-0.70
FY 2018-12-31
146.00K
146.00K
--
--
19.92M
34.13M
--
--
--
54.05M
--
-53.91M
158.00K
--
631.00K
158.00K
-53.12M
--
-53.12M
--
-53.12M
137.25M
--
--
0.95
FY 2017-12-31
6.39M
6.39M
--
--
14.80M
45.08M
--
--
--
59.88M
--
-53.49M
-1.29M
--
465.00K
-1.29M
-54.32M
--
-54.32M
--
-54.32M
-73.26M
--
--
-0.54
FY 2016-12-31
6.86M
6.86M
--
--
14.38M
157.79M
--
--
--
172.17M
--
-165.31M
-124.00K
--
134.00K
-124.00K
-165.30M
--
-165.30M
--
-165.30M
-172.42M
--
--
-1.32
FY 2015-12-31
4.33M
4.33M
--
--
17.65M
106.78M
--
--
--
124.43M
--
-120.10M
0.00
--
12.00K
0.00
-120.09M
--
-120.09M
--
-120.09M
-120.09M
--
--
-0.96

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ZIOP latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze ZIOPHARM Oncolgy recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.